CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Revenue
Operating expense
Research and development	745,945	368,954
General and administrative	2,944,377	1,639,068
Total operating expenses	3,690,322	2,008,022
Loss from operations	(3,690,322)	(2,008,022)
Other income (expense)
Interest income	332,240	22,450
Interest expense		(76,831)
Accretion of debt discount		(58,438)
Total other income (expense)	332,240	(112,819)
Net loss	$ (3,358,082)	$ (2,120,841)
Basic and Diluted Loss per Common Share	$ (0.04)	$ (0.03)
Weighted average number of common shares outstanding - basic and diluted	87,237,053	77,748,437